(Q46526541)

22 December 2017

title

Implications of statin adverse effects in the elderly (English)

1 reference

22 December 2017

author name string

Beatrice Alexandra Golomb

series ordinal

1

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

22 December 2017

Expert Opinion on Drug Safety

published in

1 reference

22 December 2017

volume

4

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

389-397

1 reference

22 December 2017

The association between lipid levels and the risks of incident myocardial infarction, stroke, and total mortality: The Cardiovascular Health Study

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Total cholesterol and mortality in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Total but not high-density lipoprotein cholesterol is consistently associated with coronary heart disease mortality in elderly men in Finland, Italy, and The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Serum total cholesterol and systolic blood pressure as risk factors for mortality from ischemic heart disease among elderly men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Low cholesterol, mortality, and quality of life in old age during a 39-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Low and lowered cholesterol and total mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Long-term prognostic importance of total cholesterol in elderly survivors of an acute myocardial infarction: the Cooperative Cardiovascular Pilot Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Circulation impact factor is highest ever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Total cholesterol and risk of mortality in the oldest old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Cardiovascular mortality predictors in the oldest old

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Aging and total cholesterol levels: cohort, period, and survivorship effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur studies of successful aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Role of glia in synapse development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Role of glia-derived cholesterol in synaptogenesis: new revelations in the synapse-glia affair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Report of the Conference on Low Blood Cholesterol: Mortality Associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Pleiotropic effects of statins: do they matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Hypothesis: atorvastatin has pleiotropic effects that translate into early clinical benefits on cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Management of lipid disorders in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Underuse of statins among older people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Simvastatin-induced lactic acidosis: a rare adverse reaction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Statin myotoxicity is associated with changes in the cardiopulmonary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Statin-associated myopathy with normal creatine kinase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Oxidation injury in patients receiving HMG-CoA reductase inhibitors: occurrence in patients without enzyme elevation or myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Mitochondrial dysfunction is a common phenotype in aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

The role of oxidative damage in mitochondria during aging: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Mitochondrial DNA repair and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Oxidative damage to mitochondria and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Mitochondria, aging and longevity--a new perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Mitochondrial DNA in aging and degenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Mitochondria, oxidative stress and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

An update on the mitochondrial-DNA mutation hypothesis of cell aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Mitochondrial DNA mutations associated with aging and degenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

HMG-CoA reductase inhibitors and myotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Polymyositis induced or associated with lipid-lowering drugs: five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Polymyositis associated with simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Simvastatin-associated dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Atorvastatin-induced dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Lovastatin-associated dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Effects of lovastatin on cognitive function and psychological well-being

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Statin-associated memory loss: analysis of 60 case reports and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Cognitive impairment associated with atorvastatin and simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

The UCSD Statin Study: a randomized controlled trial assessing the impact of statins on selected noncardiac outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Carcinogenicity of lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Low plasma cholesterol predicts an increased risk of lung cancer in elderly women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Coenzyme Q10 can in some circumstances block apoptosis, and this effect is mediated through mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Coenzyme Q10 as a possible treatment for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Parkinsonism unmasked by lovastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Cerebellar ataxia and coenzyme Q10 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Cholesterol and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Cholesterol and Alzheimer's disease: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Cholesterol, statins and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Estrogen and Alzheimer's disease: the story so far.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

A comparative review of the risks and benefits of hormone replacement therapy regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Cholesterol and cognition: rationale for the AD cholesterol-lowering treatment trial and sex-related Differences in beta-amyloid accumulation in the brains of spontaneously hypercholesterolemic Watanabe rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Link between heart disease, cholesterol, and Alzheimer's disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Impact of mild cognitive impairment on survival in very elderly people: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Health, cognitive, and psychosocial factors as predictors of mortality in an elderly community sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Mortality in nondemented subjects with cognitive impairment: the influence of health-related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Blood pressure and mortality in elderly people aged 85 and older: community based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Predictors of recovery in activities of daily living among disabled older persons living in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

Introduction. Oxidative stress in mitochondria disorders of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.3.389

21 January 2018

Identifiers

DOI

10.1517/14740338.4.3.389

1 reference

22 December 2017

1 reference

22 December 2017